Evidence map›Paper›PMID 33070015›Full record

ReviewCurrent opinion in microbiology2021

The tale of two flaviviruses: subversion of host pathways by RNA shapes in dengue and hepatitis C viral RNA genomes.

Shwetha Shivaprasad, Peter Sarnow

Abstract readReview
In one paragraph

Review in Current opinion in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shwetha ShivaprasadDepartment of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Peter SarnowDepartment of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: psarnow@stanford.edu.

Funding

Roles for microRNA-122 in hepatitis C virus RNA amplificationR01AI069000 · NIAID · STANFORD UNIVERSITY · PI SARNOW, PETER · 2006 to 2022
$6.2M
Structure and Function of the Hepatitis C Virus GenomeR37AI047365 · NIAID · STANFORD UNIVERSITY · PI SARNOW, PETER · 2011 to 2019
$4.0M
THE PROKARYOTIC-LIKE IRES IN HCV AS A DRUG TARGETR01AI047365 · NIAID · STANFORD UNIVERSITY · PI PUGLISI, JOSEPH D, SARNOW, PETER · 1999 to 2010
$3.8M
Roles for hepatitis C virus-derived circular RNAs in infected cellsR21AI151715 · NIAID · STANFORD UNIVERSITY · PI SARNOW, PETER · 2021 to 2022
$433k
NIAID NIH HHS R01 AI047365NIAID NIH HHS R01 AI069000NIAID NIH HHS R21 AI151715NIAID NIH HHS R37 AI047365
6 · The paper itself

Abstract

Pathogenic RNA viruses continue to emerge owing to their rapid evolutionary rates. The family of the Flaviviridae contains enveloped, single-stranded, positive-sense RNA viruses that include mosquito borne viruses such as dengue virus and the blood-borne hepatitis C virus. Upon infection, the genomic viral RNA needs to first compete with a sea of host mRNAs for host ribosomes that synthesize the viral proteins. Then, the positive-sense template needs to be amplified and packaged into newly assembled virions. To accomplish these tasks, the virus subverts several biochemical machineries from the host. The participation of specific structures in the viral RNA mediates specific RNA-RNA and RNA-protein interactions that dictate many viral subversion strategies. In this review, we shall focus on the various mechanisms by which RNA elements in the dengue virus and hepatitis C virus untranslated regions aid the viral infectious cycle and contribute to viral fitness.

Indexed as

Dengue VirusGenome, ViralHepacivirusHost Microbial InteractionsAnimalsDengueHepatitis CHumansRNA, ViralVirus ReplicationRNA, Viral

Identifiers

PMID33070015
PMCPMC7854966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.